These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 29212236)

  • 1. Growth differentiation factor 15 mediates epithelial mesenchymal transition and invasion of breast cancers through IGF-1R-FoxM1 signaling.
    Peake BF; Eze SM; Yang L; Castellino RC; Nahta R
    Oncotarget; 2017 Nov; 8(55):94393-94406. PubMed ID: 29212236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-like growth factor-1 receptor signaling increases the invasive potential of human epidermal growth factor receptor 2-overexpressing breast cancer cells via Src-focal adhesion kinase and forkhead box protein M1.
    Sanabria-Figueroa E; Donnelly SM; Foy KC; Buss MC; Castellino RC; Paplomata E; Taliaferro-Smith L; Kaumaya PT; Nahta R
    Mol Pharmacol; 2015 Feb; 87(2):150-61. PubMed ID: 25391374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth differentiation factor-15: a p53- and demethylation-upregulating gene represses cell proliferation, invasion, and tumorigenesis in bladder carcinoma cells.
    Tsui KH; Hsu SY; Chung LC; Lin YH; Feng TH; Lee TY; Chang PL; Juang HH
    Sci Rep; 2015 Aug; 5():12870. PubMed ID: 26249737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IR-A/IGF-1R-mediated signals promote epithelial-mesenchymal transition of endometrial carcinoma cells by activating PI3K/AKT and ERK pathways.
    Wang C; Su K; Zhang Y; Zhang W; Zhao Q; Chu D; Guo R
    Cancer Biol Ther; 2019; 20(3):295-306. PubMed ID: 30426831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GDF15 promotes epithelial-to-mesenchymal transition in colorectal [corrected].
    Zhang Y; Wang X; Zhang M; Zhang Z; Jiang L; Li L
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):652-658. PubMed ID: 29771147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correction: Growth differentiation factor 15 mediates epithelial mesenchymal transition and invasion of breast cancers through IGF-1R-FoxM1 signaling.
    Peake BF; Eze SM; Yang L; Castellino RC; Nahta R
    Oncotarget; 2020 Nov; 11(44):4074-4075. PubMed ID: 33216843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GDF15 Contributes to Radioresistance by Mediating the EMT and Stemness of Breast Cancer Cells.
    Zhao X; Liu X; Hu S; Pan Y; Zhang J; Tai G; Shao C
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance to HER2-targeted therapies: a potential role for FOXM1.
    Peake BF; Nahta R
    Breast Cancer Manag; 2014; 3(5):423-431. PubMed ID: 25598845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FOXM1 promotes the epithelial to mesenchymal transition by stimulating the transcription of Slug in human breast cancer.
    Yang C; Chen H; Tan G; Gao W; Cheng L; Jiang X; Yu L; Tan Y
    Cancer Lett; 2013 Oct; 340(1):104-12. PubMed ID: 23856032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of Adipocytokine-Mediated Trastuzumab Resistance in HER2-Positive Breast Cancer Cell Lines.
    Griner SE; Wang KJ; Joshi JP; Nahta R
    Curr Pharmacogenomics Person Med; 2013 Mar; 11(1):31-41. PubMed ID: 24179558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner.
    Shao S; Zhao X; Zhang X; Luo M; Zuo X; Huang S; Wang Y; Gu S; Zhao X
    Mol Cancer; 2015 Feb; 14(1):28. PubMed ID: 25645291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-like growth factor receptor signaling in breast tumor epithelium protects cells from endoplasmic reticulum stress and regulates the tumor microenvironment.
    Obr AE; Kumar S; Chang YJ; Bulatowicz JJ; Barnes BJ; Birge RB; Lazzarino DA; Gallagher E; LeRoith D; Wood TL
    Breast Cancer Res; 2018 Nov; 20(1):138. PubMed ID: 30458886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WNT5A signaling impairs breast cancer cell migration and invasion via mechanisms independent of the epithelial-mesenchymal transition.
    Prasad CP; Chaurasiya SK; Guilmain W; Andersson T
    J Exp Clin Cancer Res; 2016 Sep; 35(1):144. PubMed ID: 27623766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of Tumor Growth, Metastasis, and Signaling Pathways by Reducing FOXM1 Activity in Triple Negative Breast Cancer.
    Dey P; Wang A; Ziegler Y; Kim SH; El-Ashry D; Katzenellenbogen JA; Katzenellenbogen BS
    Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32961773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Signatures of the Insulin-like Growth Factor 1-mediated Epithelial-Mesenchymal Transition in Breast, Lung and Gastric Cancers.
    Cevenini A; Orrù S; Mancini A; Alfieri A; Buono P; Imperlini E
    Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30111747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer-associated fibroblasts promote epithelial-mesenchymal transition and EGFR-TKI resistance of non-small cell lung cancers via HGF/IGF-1/ANXA2 signaling.
    Yi Y; Zeng S; Wang Z; Wu M; Ma Y; Ye X; Zhang B; Liu H
    Biochim Biophys Acta Mol Basis Dis; 2018 Mar; 1864(3):793-803. PubMed ID: 29253515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
    Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
    World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocyte growth factor-induced mesenchymal-epithelial transition factor activation leads to insulin-like growth factor 1 receptor inhibitor unresponsiveness in gastric cancer cells.
    Liu R; Tang W; Han X; Geng R; Wang C; Zhang Z
    Oncol Lett; 2018 Nov; 16(5):5983-5991. PubMed ID: 30333869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paracrine recruitment and activation of fibroblasts by c-Myc expressing breast epithelial cells through the IGFs/IGF-1R axis.
    De Vincenzo A; Belli S; Franco P; Telesca M; Iaccarino I; Botti G; Carriero MV; Ranson M; Stoppelli MP
    Int J Cancer; 2019 Nov; 145(10):2827-2839. PubMed ID: 31381136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IGF-1 Receptor Modulates FoxO1-Mediated Tamoxifen Response in Breast Cancer Cells.
    Vaziri-Gohar A; Zheng Y; Houston KD
    Mol Cancer Res; 2017 Apr; 15(4):489-497. PubMed ID: 28096479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.